Eye Specialists of Carolina announced that medical director, Dr. Dean Dornic, has been certified to perform corneal transplants with the AlphaCor artificial cornea.
(Vocus) June 15, 2009 -- Eye Specialists of Carolina announced that medical director, Dr. Dean Dornic, has been certified to perform corneal transplants with the AlphaCor artificial cornea. A shortage in donor corneas or graft rejection leaves millions of patients worldwide blind from corneal disorders. An artificial cornea, the AlphaCor implant has been developed to help ameliorate the problem. Dr. Dean Dornic of Raleigh, NC is the first private practice ophthalmologist in North Carolina to be certified in its use.
Corneal transplants bring back sight to thousands of patients with diseased or scarred corneas every year but a shortage in donor corneas, graft rejection or the unsuitability of some patients to receive corneal transplants leave millions of patients worldwide blind from corneal disorders. Dr. Dean Dornic of Eye Specialists of Carolina recently became the first private practice ophthalmologist in North Carolina to be certified in the use of the AlphaCor implant; an artificial cornea designed to be used in high risk cases.
Dr. Dornic, one of the nation's foremost leaders in cataract and cornea disease, performs thousands of cataract and corneal surgeries each year including corneal transplants, partial corneal transplants, Intacs and other vision correction procedures.
"The AlphaCor Implant is a welcome addition to our armamentarium in treating corneal disease." said Dornic. "Corneal blindness is devastating to patients and can be a frustating problem for both the patient and doctor."
The AlphaCor implant is a product of Addition Technology an ophthalmic medical device developer and manufacturer in Des Plaines, IL. AlphaCor is a biocompatible, flexible, one-piece artificial cornea (keratoprosthesis) designed to replace a scarred or diseased native cornea. AlphaCor is designed for use in patients who have had multiple failed corneal transplants or in those patients in whom a donor graft is likely to fail. Its patented design features are aimed to promote retention, minimize post-operative complications and restore vision in patients who cannot receive, or are unlikely to have a beneficial outcome from, a human donor graft.
About Dr. Dornic
Dean Dornic MD is accustomed to pioneering in ophthalmology. He has offered Raleigh-Durham residents access to cutting-edge refractive surgery and cataract procedures since 2001. He is the only private practice ophthalmologist in the area to perform Intacs, a corneal insert used in the treatment of keratoconus. He is also the first ophthalmologist in the area to perform IntraLase, an all laser LASIK procedure. One of the Carolina's most experienced and qualified refractive surgeons, Dornic is a board certified, fellowship-trained, vision correction specialist dedicated to the highest standards in ophthalmic surgery. Dornic is a renowned author, lecturer and one of only 100 LASIK Gold surgeons in the country - an honor awarded by Laser Vision Centers, Inc. Recently Dr. Dornic was named to Consumers' Research Council of America's list of "Top Ophthalmologists."
Dornic has offices in Cary and Smithfield, NC and is on staff at Rex Hospital, Johnston Health and Wake Medical Centers. For more information about Dr. Dean Dornic or his office locations, visit the Laser Eye Center of Carolina online at http://www.visionauthorities.com or his Smithfield, NC practice at http://www.eyespecialistsofcarolina.com.
About Addition Technology
Addition Technology, Inc. is a privately held eye care company, specializing in novel solutions for sight-threatening eye indications. Intacs® corneal implants and the AlphaCor™ artificial cornea are patented devices, and the first of their kind, approved by the FDA and granted CE Mark certification in Europe in addressing vision threatening conditions of the cornea. Intacs corneal implants are indicated for keratoconus and myopia. AlphaCor artificial cornea is indicated as an alternative for high-risk, repeat graft failures.
Both products are distributed worldwide. For more information visit http://www.additiontechnology.com/
Becca Glover, 3 Dog Agency
# # #
Read the full story at http://www.prweb.com/releases/Dr_Dean_Dornic/Addition_Technology/prweb2525974.htm.
Copyright©2009 Vocus, Inc.
All rights reserved